EHA 2023 | The current standard of care in hemophilia and unmet needs in this space
Michiel Coppens, MD, PhD, Amsterdam UMC, Amsterdam, The Netherlands, briefly discusses the current standard of care (SOC) in hemophilia, highlighting the role of factor replacement therapy. Dr Coppens also discusses limitations associated with factor replacement therapy and comments on the need to improve treatment options for patients. This interview took place at the 28th Congress of the European Hematology Association (EHA) 2023 in Frankfurt, Germany.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Disclosures
Grant/research support: Anthos, Bayer, CSL Behring/UniQure, Novo Nordisk, Roche
Lecturing/consultancy: Alexion, CSL Behring, Daiichi Sankyo, Sobi, Viatris
Member EAHAD Gene Therapy working group, ERN-EuroBloodNet
